1. Prevention of meningococcal disease by group C polysaccharide vaccine;Artenstein M. S.;New Engl. J. Med.,1970
2. Mucosal immunology;Bienenstock J.;Immunology,1980
3. Brinton C. C. J. Bryan J. Dillon N. Guerina L. J. Jacobson A. Labik S. Lee A. Levine S. Lim J. McMichael S. Polen K. Rogers A. C.-C. To and S. C.-M. To. 1978. Uses of pili in gonorrhea control: role of bacterial pili in disease purification and properties of gonococcal pili and progress in the development of a gonococcal pilus vaccine for gonorrhea p. 155-178. In G. F. Brooks E. C. Gotschlich K. K. Holmes W. D. Sawyer and F. E. Young (ed.) Immunobiology of Neisseria gonorrhoeae. American Society for Microbiology Washington D.C.
4. .Brinton C. C. S. W. Wood A. Brown A. M. Lablk J. R. Bryan S. W. Lee S. E. Polen E. C. Tramont J. Sadoff and W. Zolinger. 1982. The development of a neisserial pilus vaccine for gonorrhea and meningococcal meningitis p. 140-159. In J. Robbins J. Hill and J. Sadoff (ed.) Seminars in infectious disease vol. IV. Thieme-Stratton New York.
5. Effect of local infection and oral contraception immunoglobulin levels in cervical mucus;Chipperfield E. J.;Infect. Immun.,1975